{"id":"https://openalex.org/W3083351245","doi":"https://doi.org/10.1158/1538-7445.am2020-5195","title":"Abstract 5195: NBL-015, a next-generation fully human anti-claudin 18.2 antibody with enhanced ADCC and CDC for treating gastric and pancreatic cancers","display_name":"Abstract 5195: NBL-015, a next-generation fully human anti-claudin 18.2 antibody with enhanced ADCC and CDC for treating gastric and pancreatic cancers","publication_year":2020,"publication_date":"2020-08-15","ids":{"openalex":"https://openalex.org/W3083351245","doi":"https://doi.org/10.1158/1538-7445.am2020-5195","mag":"3083351245"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2020-5195","doi":"https://doi.org/10.1158/1538-7445.am2020-5195","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2020-5195","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101873410","display_name":"Ming Lei","orcid":"https://orcid.org/0000-0002-3799-9570","observed_orcids":["https://orcid.org/0000-0002-3799-9570"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ming Lei","raw_affiliation_strings":["NovaRock Biotherapeutics, Ewing, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NovaRock Biotherapeutics, Ewing, NJ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005907084","display_name":"Anna Przyby\u0142a","orcid":"https://orcid.org/0000-0002-6395-5731","observed_orcids":["https://orcid.org/0000-0002-6395-5731"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anna Przybyla","raw_affiliation_strings":["NovaRock Biotherapeutics, Ewing, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NovaRock Biotherapeutics, Ewing, NJ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004933934","display_name":"Ahmed Abdelghany Hassan","orcid":"https://orcid.org/0000-0003-4047-0421","observed_orcids":["https://orcid.org/0000-0003-4047-0421"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ahmed Hassan","raw_affiliation_strings":["NovaRock Biotherapeutics, Ewing, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NovaRock Biotherapeutics, Ewing, NJ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010668623","display_name":"Qingtai Su","orcid":"https://orcid.org/0000-0002-9224-3442","observed_orcids":["https://orcid.org/0000-0002-9224-3442"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Qingtai Su","raw_affiliation_strings":["NovaRock Biotherapeutics, Ewing, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NovaRock Biotherapeutics, Ewing, NJ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079988142","display_name":"Gabriela Hrebikova","orcid":"https://orcid.org/0000-0001-8551-8228","observed_orcids":["https://orcid.org/0000-0001-8551-8228"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gabriela Hrebikova","raw_affiliation_strings":["NovaRock Biotherapeutics, Ewing, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NovaRock Biotherapeutics, Ewing, NJ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085439195","display_name":"Samantha Wallner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Samantha Wallner","raw_affiliation_strings":["NovaRock Biotherapeutics, Ewing, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NovaRock Biotherapeutics, Ewing, NJ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035868689","display_name":"Danielle L. Lavery","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Danielle Lavery","raw_affiliation_strings":["NovaRock Biotherapeutics, Ewing, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NovaRock Biotherapeutics, Ewing, NJ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100350895","display_name":"Kevin Chen","orcid":"https://orcid.org/0000-0002-3851-6016","observed_orcids":["https://orcid.org/0000-0002-3851-6016"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kevin Chen","raw_affiliation_strings":["NovaRock Biotherapeutics, Ewing, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NovaRock Biotherapeutics, Ewing, NJ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109951660","display_name":"Raymond Y.-L. Yu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Raymond Yu","raw_affiliation_strings":["NovaRock Biotherapeutics, Ewing, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NovaRock Biotherapeutics, Ewing, NJ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079927920","display_name":"Joshua Dewe","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joshua Dewe","raw_affiliation_strings":["NovaRock Biotherapeutics, Ewing, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NovaRock Biotherapeutics, Ewing, NJ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110745234","display_name":"Samruddhi Patil","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Samruddhi Patil","raw_affiliation_strings":["NovaRock Biotherapeutics, Ewing, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NovaRock Biotherapeutics, Ewing, NJ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109864878","display_name":"Haichun Huang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Haichun Huang","raw_affiliation_strings":["NovaRock Biotherapeutics, Ewing, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NovaRock Biotherapeutics, Ewing, NJ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025520245","display_name":"Yi Pei","orcid":"https://orcid.org/0000-0002-3466-760X","observed_orcids":["https://orcid.org/0000-0002-3466-760X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yi Pei","raw_affiliation_strings":["NovaRock Biotherapeutics, Ewing, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NovaRock Biotherapeutics, Ewing, NJ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104299542","display_name":"Zhong Liu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhong Liu","raw_affiliation_strings":["NovaRock Biotherapeutics, Ewing, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NovaRock Biotherapeutics, Ewing, NJ","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101635365","display_name":"Han Li","orcid":"https://orcid.org/0000-0003-3089-9523","observed_orcids":["https://orcid.org/0000-0003-3089-9523"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Han Li","raw_affiliation_strings":["NovaRock Biotherapeutics, Ewing, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NovaRock Biotherapeutics, Ewing, NJ","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"80","issue":"16_Supplement","first_page":"5195","last_page":"5195"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9702000021934509,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9702000021934509,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.0066999997943639755,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.006500000134110451,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/claudin-18-2","display_name":"claudin 18.2","score":0.9549999833106995},{"id":"https://openalex.org/keywords/gastric-cancer","display_name":"gastric cancer","score":0.7559999823570251},{"id":"https://openalex.org/keywords/pancreatic-cancer","display_name":"pancreatic cancer","score":0.9990000128746033},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.796999990940094},{"id":"https://openalex.org/keywords/complement-dependent-cytotoxicity","display_name":"complement-dependent cytotoxicity","score":0.972000002861023},{"id":"https://openalex.org/keywords/fc-engineering","display_name":"Fc engineering","score":0.8389999866485596},{"id":"https://openalex.org/keywords/zolbetuximab","display_name":"zolbetuximab","score":0.8309999704360962}],"concepts":[{"id":"https://openalex.org/C40677261","wikidata":"https://www.wikidata.org/wiki/Q21418091","display_name":"Antibody-dependent cell-mediated cytotoxicity","level":4,"score":0.6005160212516785},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5949183106422424},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5764609575271606},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.574531614780426},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4875778555870056},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.43087801337242126},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3458102345466614},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.26967954635620117},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.12577000260353088}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2020-5195","doi":"https://doi.org/10.1158/1538-7445.am2020-5195","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2020-5195","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9922999739646912}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8199999928474426}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2021484614","https://openalex.org/W2035753258","https://openalex.org/W2021039830","https://openalex.org/W2089163673","https://openalex.org/W3207509824","https://openalex.org/W2067233183","https://openalex.org/W2081127096","https://openalex.org/W13771988","https://openalex.org/W1968138362","https://openalex.org/W2093260703"],"abstract_inverted_index":{"Abstract":[0],"Claudin":[1],"18.2":[2,377],"is":[3,24,38,90,127,163,174,222,320,330],"a":[4,65,91,154,164,296,372],"member":[5],"of":[6,15,56,125,217,295,393,397],"the":[7,13,81,84,123,132,137,150,195,246,250,290,394,398],"claudin":[8],"family":[9],"and":[10,30,49,60,75,104,129,135,158,173,181,190,207,229,244,263,273,281,293,306,316,325,382,387,408],"belongs":[11],"to":[12,26,69,140,145,152,176,194,204,214,225,245,270,332],"class":[14],"tight":[16],"junction":[17],"proteins.":[18],"Its":[19],"expression":[20,54,121,148],"on":[21,31],"normal":[22,61],"tissue":[23],"restricted":[25],"gastric":[27,109,208,262,280,386],"cell":[28,210],"lineage":[29],"short-lived":[32],"differentiated":[33],"epithelial":[34],"cells,":[35],"while":[36],"it":[37,64,191],"expressed":[39],"in":[40,108,115,122,249,260,274,314,317,322,336],"multiple":[41,205,261],"cancer":[42],"types,":[43],"including":[44],"pancreatic,":[45],"stomach,":[46],"esophageal,":[47],"lung":[48],"ovarian":[50],"cancers.":[51],"The":[52],"differential":[53],"pattern":[55],"claudin18.2":[57,113,120,147],"between":[58],"tumor":[59,117,209,265],"tissues":[62],"makes":[63],"promising":[66],"drug":[67,139],"target":[68],"treat":[70],"those":[71],"cancers,":[72],"especially":[73],"pancreatic":[74,206,264,282,388],"gastroesophageal":[76],"tumors,":[77],"which":[78],"are":[79],"among":[80],"malignancies":[82],"with":[83,111,143,178,238,240,379],"highest":[85],"unmet":[86],"medical":[87],"need.":[88],"Zolbetuximab":[89],"mouse-human":[92],"chimeric":[93],"antibody":[94,151,167,248,304,378],"developed":[95],"by":[96],"Astellas":[97],"Pharma.":[98],"It":[99,200,232,319,329],"exhibits":[100,201,310],"encouraging":[101],"clinical":[102,334],"efficacy":[103,259],"good":[105],"safety":[106],"data":[107,288],"patients":[110,142],"mid-high":[112],"expressing":[114,212,268],"their":[116],"tissues.":[118],"However,":[119],"majority":[124],"tumors":[126],"moderate":[128,144,213,269],"heterogeneous.":[130],"Expanding":[131],"therapeutic":[133],"window":[134],"allowing":[136],"anti-cladudin18.2":[138],"benefit":[141],"low":[146,179,215,271],"require":[149],"have":[153],"higher":[155],"binding":[156,203],"affinity":[157],"strong":[159,202],"killing":[160],"activity.":[161],"NBL-015":[162,184,221,254,309],"fully":[165,374],"human":[166,375],"generated":[168],"from":[169],"Tranni":[170],"transgenic":[171],"mouse":[172],"predicted":[175],"bear":[177],"development":[180,307,324],"immunogenicity":[182],"risks.":[183],"demonstrates":[185,256],"high":[186],"selectivity":[187],"against":[188],"claudin18.2,":[189,272],"doesn't":[192],"bind":[193],"close":[196],"splicing":[197],"variant":[198],"claudin18.1.":[199],"lines":[211],"level":[216],"CLDN18.2":[218],"endogenously.":[219],"Moreover,":[220],"Fc":[223,243],"engineered":[224],"enhance":[226],"both":[227],"ADCC":[228,381],"CDC":[230,383],"activities.":[231],"shows":[233],"robust":[234],"tumor-killing":[235],"activity":[236,313],"comparing":[237],"antibodies":[239],"wild":[241],"type":[242],"benchmark":[247],"ex":[251],"vivo":[252],"models.":[253],"also":[255],"superior":[257],"anti-tumor":[258,312],"CDX":[266,283],"models":[267],"PBMC":[275],"humanized":[276],"NOG":[277],"mice":[278],"bearing":[279],"tumors.":[284],"In":[285],"conclusion,":[286],"our":[287],"confirm":[289],"successful":[291],"discovery":[292,305],"optimization":[294],"next-generation":[297,373],"anti-claudin18.2":[298],"mAb,":[299],"NBL-015,":[300,371],"using":[301],"NovaRock's":[302],"proprietary":[303],"platforms.":[308],"potent":[311],"vitro":[315],"vivo.":[318],"currently":[321],"process":[323],"IND":[326],"enabling":[327],"studies.":[328],"targeted":[331],"enter":[333],"studies":[335],"early":[337],"2021.":[338],"Citation":[339],"Format:":[340],"Ming":[341],"Lei,":[342],"Anna":[343],"Przybyla,":[344],"Ahmed":[345],"Hassan,":[346],"Qingtai":[347],"Su,":[348],"Gabriela":[349],"Hrebikova,":[350],"Samantha":[351],"Wallner,":[352],"Danielle":[353],"Lavery,":[354],"Kevin":[355],"Chen,":[356],"Raymond":[357],"Yu,":[358],"Joshua":[359],"Dewe,":[360],"Samruddhi":[361],"Patil,":[362],"Haichun":[363],"Huang,":[364],"Yi":[365],"Pei,":[366],"Zhong":[367],"Liu,":[368],"Han":[369],"Li.":[370],"anti-claudin":[376],"enhanced":[380],"for":[384,401],"treating":[385],"cancers":[389],"[abstract].":[390],"In:":[391],"Proceedings":[392],"Annual":[395],"Meeting":[396],"American":[399],"Association":[400],"Cancer":[402,414],"Research":[403],"2020;":[404],"2020":[405],"Apr":[406],"27-28":[407],"Jun":[409],"22-24.":[410],"Philadelphia":[411],"(PA):":[412],"AACR;":[413],"Res":[415],"2020;80(16":[416],"Suppl):Abstract":[417],"nr":[418],"5195.":[419]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1}],"updated_date":"2026-10-17T09:40:24.721904","created_date":"2025-10-10T00:00:00"}